Study population 24 hours after STEMI
| Variable . | All patients (N = 361) . |
|---|---|
| Characteristics | |
| Age, y | 64 ± 12 |
| Sex, n (%) | |
| Female | 73 (20) |
| Male | 288 (80) |
| BMI, kg/m2 | 27.0 ± 4.2 |
| Disorders, n (%) | |
| Arterial hypertension | 230 (64) |
| Diabetes mellitus | 145 (40) |
| Hyperlipidaemia | 121 (36) |
| Smoker | 194 (54) |
| Previous MI | 38 (11) |
| Known CAD/previous PCI | 106 (29) |
| Infarct characteristics | |
| Number of diseased vessel | |
| 1-vessel disease, n (%) | 75 (21) |
| 2-vessel disease, n (%) | 71 (20) |
| 3-vessel disease, n (%) | 215 (60) |
| Blood parameter | |
| Total cholesterol, mg/dL | 143.86 ± 36.99 |
| TG, mg/dL | 136.36 ± 63.27 |
| HDL, mg/dL | 38.24 ± 11.59 |
| LDL, mg/dL | 84.72 ± 32.46 |
| Lp(a), mg/dL | 54.01 ± 64.45 |
| GFR, mL/min | 74.10 ± 24.56 |
| HbA1c, % | 6.14 ± 1.32 |
| CRP, mg/L | 4.96 ± 6.97 |
| TnT, mg/L | 2638.03 ± 4150.89 |
| CK, U/L | 520.55 ± 2089.48 |
| Preexisting antiplatelet therapy | 119 (33) |
| Aspirin | 110 (30) |
| P2Y12 inhibitor | 30 (8) |
| Variable . | All patients (N = 361) . |
|---|---|
| Characteristics | |
| Age, y | 64 ± 12 |
| Sex, n (%) | |
| Female | 73 (20) |
| Male | 288 (80) |
| BMI, kg/m2 | 27.0 ± 4.2 |
| Disorders, n (%) | |
| Arterial hypertension | 230 (64) |
| Diabetes mellitus | 145 (40) |
| Hyperlipidaemia | 121 (36) |
| Smoker | 194 (54) |
| Previous MI | 38 (11) |
| Known CAD/previous PCI | 106 (29) |
| Infarct characteristics | |
| Number of diseased vessel | |
| 1-vessel disease, n (%) | 75 (21) |
| 2-vessel disease, n (%) | 71 (20) |
| 3-vessel disease, n (%) | 215 (60) |
| Blood parameter | |
| Total cholesterol, mg/dL | 143.86 ± 36.99 |
| TG, mg/dL | 136.36 ± 63.27 |
| HDL, mg/dL | 38.24 ± 11.59 |
| LDL, mg/dL | 84.72 ± 32.46 |
| Lp(a), mg/dL | 54.01 ± 64.45 |
| GFR, mL/min | 74.10 ± 24.56 |
| HbA1c, % | 6.14 ± 1.32 |
| CRP, mg/L | 4.96 ± 6.97 |
| TnT, mg/L | 2638.03 ± 4150.89 |
| CK, U/L | 520.55 ± 2089.48 |
| Preexisting antiplatelet therapy | 119 (33) |
| Aspirin | 110 (30) |
| P2Y12 inhibitor | 30 (8) |
Data are presented as mean ± standard deviation or number (percent) of patients.
CAD, coronary artery disease; CK, creatine phosphokinase; CRP, C-reactive protein; GFR, glomerular filtration rate calculated by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation; HbA1c, glycosylated hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein; Lp(a), lipoprotein (a); MI, myocardial infarction; TG, triglycerides; TnT, troponin T.